Experimental studies of AD mouse models have demonstrated that, when treated with pregnane X receptor (PXR) agonists, which play a pivotal role in enhancing the expression of P-gp, exhibited a pronounced efflux of exogenous Aβ, which is central to the pathology of AD [213]. This evidence concerns the gene NR1I2 and Alzheimer disease.